46 results for "Ruide Li"
Showing 1–20 · 0.33 seconds · RSS
-
Journal Article
From bench to body: In vivo CAR engineering in the clinic
In vivo CAR engineering is an emerging therapeutic platform for cancer and autoimmune diseases. Enabled by advanced delivery systems such as immune-evasive lentiviral vectors and targeted lipid nanoparticles, this strategy has progressed to early clinical testing, showing initial safety and…
-
Journal Article
Protocol to generate human stem cell-derived CD70-directed allogeneic CAR-NKT cells for treating renal cell carcinoma
…details on the use and execution of this protocol, please refer to Li et al.1 : Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.
-
Journal Article Full text
iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
Chimeric Antigen Receptor (CAR)-engineered T (CAR-T) cell therapy represents a highly promising modality within the domain of cancer treatment. CAR-T cell therapy has demonstrated notable efficacy in the treatment of hematological malignancies, solid tumors, and various infectious diseases…
-
Journal Article Full text
Dual-Branch Diffusion Detection Model for Photovoltaic Array and Hotspot Defect Detection in Infrared Images
Failures in solar photovoltaic (PV) modules generate heat, leading to various hotspots observable in infrared images. Automated hotspot detection technology enables rapid fault identification in PV systems, while PV array detection, leveraging geometric cues from infrared images, facilitates the…
-
Journal Article
Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
Abstract Cell-based immunotherapies (CBIs), notably exemplified by chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy, have emerged as groundbreaking approaches for cancer therapy. Nevertheless, akin to various other therapeutic modalities, tumor cells employ counterstrategies to…
-
Journal Article
Exploring CAR cell therapies beyond CAR-T for myeloid malignancies
Abstract Chimeric antigen receptor (CAR)-T cells have demonstrated remarkable efficacy in several hematologic malignancies; however, their application in myeloid malignancies such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) remains limited, with no FDA-approved products to…
-
Journal Article
Advances in antibody-drug conjugates in cancer: latest updates from the 2026 AACR annual meeting
Abstract Antibody-drug conjugates (ADCs) are rapidly evolving from conventional cytotoxic delivery systems into multifunctional, immune-integrated therapeutic platforms. Highlights from the 2026 American Association for Cancer Research (AACR) Annual Meeting demonstrate significant advances in ADC…
-
Journal Article
Emerging artificial intelligence advances in oncology: latest updates from the 2026 AACR annual meeting
Abstract Advances presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting highlight a shift from standalone artificial intelligence (AI) models to integrated, agentic systems across oncology. Platforms such as Synapse enable large-scale data coordination, supporting…
-
Journal Article
Frontiers of cytokine engineering in CAR cell therapy for cancer
Chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy has revolutionized the treatment of hematologic malignancies, yet its efficacy in solid tumors remains limited by T cell exhaustion, restricted tumor infiltration, and an immunosuppressive tumor microenvironment (TME). Recent…
-
Journal Article Full text
Characterization of Plant Defensin (PDF) Genes in Banana (Musa acuminata) Reveals the Antifungal Ability of MaPDF2.2 to Fusarium Wilt Pathogens
Plant defensin (PDF/DEF), an important pathogenesis-related protein which widely exists in plants, displays broad-spectrum antifungal activities. To date, however, reports on the banana PDFs are very limited. In this study, we identified, cloned, and characterized the five Class I PDFs…
-
Journal Article
Innovative gene engineering strategies to address tumor antigen escape in cell therapy
Abstract Tumor antigen escape limits the durability of antigen-specific immunotherapies, particularly chimeric antigen receptor (CAR)-based treatments. Malignant cells evade detection through six routes: antigen mutation or alternative splicing, impaired antigen processing, lineage switching…
-
Journal Article
Navigating the gastric frontier of mucosal immunity against Helicobacter pylori
Helicobacter pylori (H. pylori) is a globally prevalent bacterium that causes chronic infection and, while often asymptomatic, is a major cause of gastritis, peptic ulcer disease, and a risk factor for gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. Infection triggers…
-
Journal Article
Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies
Abstract Cancer stem cells (CSCs) have emerged as key contributors to tumor initiation, growth, and metastasis. In addition, CSCs play a significant role in inducing immune evasion, thereby compromising the effectiveness of cancer treatments. The reciprocal communication between CSCs and the tumor…
-
Journal Article
Large language model-guided CAR-T in silico platform for cytokine optimization in liver cancer with low antigen density
Abstract CAR-T cell therapy has shown remarkable success in hematologic malignancies but remains limited in solid tumors such as liver cancer due to antigen heterogeneity, low target antigen density, and an immunosuppressive tumor microenvironment (TME). Cytokine engineering can enhance CAR-T…
-
Journal Article Full text
Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies
Cell-based cancer immunotherapy has revolutionized the treatment of hematological malignancies. Specifically, autologous chimeric antigen receptor-engineered T (CAR-T) cell therapies have received approvals for treating leukemias, lymphomas, and multiple myeloma following unprecedented clinical…
-
Journal Article Full text
Insights into the Underlying Mechanism of the Piriformospora indica-Enhanced Drought Tolerance in Blueberry
Piriformospora/Serendipita indica has been frequently proved to play a crucial role in enhancing plant adaptation to environmental stresses. However, its influence on blueberry (Vaccinium corymbosum) drought tolerance has not yet been studied. Here, we reported that P. indica colonization can…
-
Journal Article Full text
The Growth-Promoting Effects of Piriformospora indica on Banana Under Different Concentrations of Phosphorus and Potassium Treatments
Banana plants require substantial nutrients, and their growth is significantly hindered by nutrient deficiency. This study investigated the influences of Piriformospora indica colonization on the growth of clean river sand-cultivated banana plants under varying phosphorus (P) and potassium (K)…
-
Journal Article
Piriformospora indica culture filtrate application adds brilliance to the promoting effects of facility warming on winter jujube fruit ripening
Facility warming can promote fruit ripening of winter jujube (Zizyphus jujuba Mill. cv. Dongzao, DZ) for pre-marketing. Here, we compared the fruit development- and quality-related parameters of facility cultivated DZ trees grown at maximum temperature of 37 °C, 39.5 °C and 42 °C with and without…
-
Journal Article
Target tumor microenvironment by innate T cells
The immunosuppressive tumor microenvironment (TME) remains one of the most prevailing barriers obstructing the implementation of effective immunotherapy against solid-state cancers. Eminently composed of immunosuppressive tumor associated macrophages (TAMs) and myeloid-derived suppressor cells…
-
Journal Article
Addressing graft-versus-host disease in allogeneic cell-based immunotherapy for cancer
Abstract Allogeneic cell-based immunotherapies, particularly CAR-T cell therapy, represent a significant advancement in cancer treatment, offering scalable and consistent alternatives to autologous therapies. However, their widespread use is limited by the risk of graft-versus-host disease (GvHD)…